Market Research Logo

Global Analgesics Market 2016-2020

About the Analgesics Market

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

Technavio’s analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Pfizer
  • Bayer HealthCare
  • Sanofi
  • Endo
  • Johnson & Johnson
  • Purdue Pharma
Other prominent vendors
  • Achelios Therapeutics
  • Alder BioPharmaceuticals
  • Allergan
  • Amgen
  • AstraZeneca
  • Baxter
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CoLucid Pharmaceuticals
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • DURECT
  • El Lilly & Company
  • F. Hoffmann La Roche
  • GlaxoSmithKline
  • GW Pharmaceuticals
  • Hospira
  • Immune Pharmaceuticals
  • Innovative Med Concepts
  • Merck
  • NeurAxon
  • Novartis
  • OptiNose
  • Pain Therapeutics
  • RedHill
  • Sorrento Therapeutics
  • Suda
  • Taro Pharmaceuticals Industries
  • Teva Pharmaceuticals Industries
  • Tonix Pharmaceuticals
  • Trigemina
  • UCB
  • Valeant Pharmaceuticals International
  • WEX Pharmaceuticals
  • Zynerba Pharmaceuticals
Market driver
  • Increase in self-medication
  • For a full, detailed list, view our report
Market challenge
  • Preference for alternative therapies
  • For a full, detailed list, view our report
Market trend
  • Accelerated use of online resources
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Analgesics Market 2016-2020

Technavio recognizes the following companies as the key players in the global analgesics market: Pfizer, Bayer HealthCare, Sanofi, Endo International, Johnson & Johnson, and Purdue Pharma.

Other Prominent Vendors in the market are: Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol Myers Squibb, CoLucid Pharmaceuticals, Daiichi Sankyo, Dr. Reddy's Laboratories, DURECT, El Lilly & Company, F. Hoffmann La Roche, GlaxoSmithKline, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts, Merck, NeurAxon, Novartis, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals, Trigemina, UCB, Valeant Pharmaceuticals International, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “A key trend which is boosting market growth is the accelerated use of online resources. Several manufacturers and retailers are shifting their marketing strategy to the online platform to achieve high-volume sales and offer convenience and comfort for end-users. For instance, websites such as vitacost.com, healthkart.com, rxexpress.co.uk, and vivavitamins.com offer pain tablets, caplets, gels, creams, and ointments. These sites provide options such as live chat to provide instant support to individuals who face difficulties when purchasing pain medication.”

According to the report, a key growth driver is the rapid industrialization in China. Changes in government policies of countries are increasing the preference for OTC drugs over prescription drugs. These drugs do not require a written prescription from healthcare professionals and can be purchased directly from pharmacy stores. This is a major factor that promotes the increased use of these products and a rise in the practice of self-medication. For instance, people with pain conditions use analgesics such as acetaminophen, aspirin, ibuprofen, and diclofenac.

Further, the report states that a major factor that could hamper market growth is the growing preference for alternative therapies. Many analgesics do not show the required long-term efficacy, which leads to patients opting for non-pharmacologic treatments for pain relief. Also, patients sometimes become allergic or experience severe side-effects from drugs or deterioration of a pre-existing disease with the use of these medications.



Companies Mentioned

Pfizer, Bayer HealthCare, Sanofi, Endo International, Johnson & Johnson, Purdue Pharma, Achelios Therapeutics, Alder BioPharmaceuticals, Allergan, Amgen, AstraZeneca, Baxter, Boehringer Ingelheim, Bristol Myers Squibb, CoLucid Pharmaceuticals, Daiichi Sankyo, Dr. Reddy's Laboratories, DURECT, El Lilly & Company, F. Hoffmann La Roche, GlaxoSmithKline, GW Pharmaceuticals, Hospira, Immune Pharmaceuticals, Innovative Med Concepts, Merck, NeurAxon, Novartis, OptiNose, Pain Therapeutics, RedHill, Sorrento Therapeutics, Suda, Taro Pharmaceuticals Industries, Teva Pharmaceuticals Industries, Tonix Pharmaceuticals, Trigemina, UCB, Valeant Pharmaceuticals International, WEX Pharmaceuticals, Zynerba Pharmaceuticals.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Assumptions
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Pain: Overview
      • Table Pain assessment
      • Table Types of pain scales
      • Table Treatment options for pain
      • Table Commonly used non-opioids for pain
      • Table Commonly used adjuvant medicines for pain
      • Table Treatment algorithm for pain
  • Pipeline portfolio
    • Table Pipeline portfolio: Major analgesic candidates under development for pain
    • Information on pipeline candidates
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global analgesics market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Global analgesics market by drug class
    • Opioids
    • NSAIDs
    • Other
      • Table Segmentation of global analgesics market by drug class 2015
      • Table Global analgesics market segmentation by drug class 2015-2020 ($ billions)
      • Table Global analgesics market segmentation by drug class 2015-2020
      • Table Global analgesics market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
    • Global opioids market
      • Table Global opioids market 2015-2020 ($ billions)
    • Global NSAIDs Market
      • Table Global NSAIDs market 2015-2020 ($ billions)
  • Market segmentation by type
    • Table Global analgesics segmentation by type
    • Table Global analgesics segmentation by type 2015
    • Table Global analgesics market segmentation by type 2015-2020 ($ billions)
    • Table Global analgesics market segmentation by type 2015-2020
    • Table Global analgesics market: YoY revenue and growth based on type 2015-2020 ($ billions)
    • Prescription analgesics
      • Table Global prescription analgesics market 2015-2020 ($ billions)
    • OTC analgesics
      • Table Global OTC analgesics market 2015-2020 ($ billions)
  • Market segmentation by application
    • Table Global analgesics market segmentation by application
    • Global internal analgesics market
      • Table Global internal analgesics market 2015-2020 ($ billions)
    • Global external analgesics market
      • Table Global external analgesics market 2015-2020 ($ billions)
      • Table Global analgesics market segmentation by application 2015-2020 ($ billions)
      • Table Global analgesics market segmentation by application 2015-2020
      • Table Global analgesics market: YoY revenue and growth based on application 2015-2020 ($ billions)
  • Market segmentation by pain type
    • Table Global analgesics market segmentation by type
    • Musculoskeletal pain
    • Surgical and trauma pain
    • Cancer pain
    • Neuropathic pain
    • Migraine
    • Obstetrical pain
    • Fibromyalgia
    • Pain due to burns
    • Dental/facial pain
    • Pediatric pain
      • Table Global analgesics market segmentation by type 2015
  • Market segmentation by ROA
    • Table Global analgesics market segmentation by ROA
    • Oral
    • Parenteral
    • Topical
    • Transdermal
    • Rectal
      • Table Global analgesics market segmentation by ROA 2015
  • Geographical segmentation
    • Table Global analgesics market by geography 2015
    • Table Global analgesics market revenue by geography 2015-2020 ($ billions)
    • Table Global analgesics market revenue by geography 2015-2020
    • Table Global analgesics market: YoY revenue and growth based on geography 2015-2020 ($ billions)
    • Analgesics market in Americas
      • Table Analgesics market in Americas 2015-2020 ($ billions)
    • Analgesics market in EMEA
      • Table Analgesics market in EMEA 2015-2020 ($ billions)
    • Analgesics market in APAC
      • Table Analgesics market in APAC 2015-2020 ($ billions)
  • Market drivers
    • Growing geriatric population
      • Table Population aged 60 years and over: World, developed, and developing regions (millions)
      • Table Expected growth of older population in US 2010-2050
    • Increase in self-medication
    • Promising pipeline
    • Favorable regulatory scenario
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Generic competition
    • Preference for alternative therapies
      • Table Alternative therapies for pain
      • Table Use of CAM therapies among individuals in US
    • Counterfeit pharmaceuticals
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Accelerated use of online resources
      • Table Global Internet penetration rate 2015
    • Increase in R&D
    • Off-label drugs use
    • Strategic alliances
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2015
      • Table Market share analysis 2015
      • Table Revenue share of major companies for global analgesics market 2015
      • Table Revenues from the sales of top five analgesics 2013-2015 ($ millions)
    • Pfizer
      • Table Pfizer: YoY revenue and growth rate of Lyrica 2013-2015 ($ billions)
      • Table Pfizer: YoY revenue and growth rate of Celebrex 2013-2015 ($ billions)
      • Table Pfizer: YoY revenue and growth rate of Relpax 2013-2015 ($ millions)
      • Table Pfizer: Key takeaways
    • Bayer Healthcare
      • Table Bayer HealthCare: YoY revenue and growth rate of Aspirin 2013-2015 ($ millions)
      • Table Bayer HealthCare: YoY revenue and growth rate of Aleve 2013-2015 ($ millions)
      • Table Bayer HealthCare: Key takeaways
    • Sanofi
      • Table Sanofi: YoY revenue and growth rate of Doliprane 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Dorflex 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of Synvisc/Synvisc One 2013-2015 ($ millions)
      • Table Sanofi: YoY revenue and growth rate of No Spa 2013-2015 ($ millions)
      • Table Sanofi: Key takeaways
    • Endo International
      • Table Endo International: YoY revenue and growth rate of Opana ER 2013-2015 ($ millions)
      • Table Endo International: YoY revenue and growth rate of Voltaren 2013-2015 ($ millions)
      • Table Endo International: YoY revenue and growth rate of Lidoderm 2013-2015 ($ millions)
      • Table Endo International: YoY revenue and growth rate of Percocet 2013-2015 ($ millions)
      • Table Endo International: Key takeaways
    • Johnson & Johnson
      • Table Johnson & Johnson: Key takeaways
    • Purdue Pharma
      • Table Purdue Pharma: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report